Why the study?
Does the addition of heparin to peripheral intravenous alimentation solutions reduce the incidence of phlebitis and improve catheter patency in premature infants?
Does the addition of heparin to peripheral intravenous alimentation solutions reduce the incidence of phlebitis and improve catheter patency in premature infants?
Adding heparin to peripheral intravenous alimentation solutions in premature infants doubles catheter patency duration and significantly reduces phlebitis without increasing complications.
Answers are grounded in this paper and cite their sources.
Supports heparin addition to peripheral IV alimentation in premature infants; confirms doubled patency and reduced phlebitis.
A randomized controlled study was done to determine whether the addition of heparin (1 U/mL) to peripheral intravenous alimentation solutions would affect the incidence of phlebitis and duration of patency of intravenous catheters in premature infants. Twenty-two-gauge Teflon catheters were uniformly used. One hundred five catheters infused with heparin were placed in 13 infants, and 122 catheters were placed in the control group of 13 infants. The time, nature, and incidence of complications were noted for each infusion site. Infusion of heparin was found to double the duration of patency of intravenous catheters and to reduce significantly the incidence of phlebitis. No complications related to the administration of heparin were noted. Heparinization of intravenous alimentation solutions should therefore be considered in premature infants as a means of reducing the work load and incidence of complications associated with peripheral lines.
No takes yet. Share an insight, caveat, or question.
Alpan et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: